Disseminated Lomentospora prolificans infection in a patient on idelalisib-rituximab therapy for relapsed chronic lymphocytic leukaemia

MeSH terms

• Antifungal Agents / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Cyclophosphamide / administration & dosage
• Cyclophosphamide / adverse effects
• Drug Resistance, Multiple, Fungal
• Drug Substitution
• Fatal Outcome
• Febrile Neutropenia / complications
• Febrile Neutropenia / drug therapy
• Female
• Filgrastim / therapeutic use
• Fluconazole / therapeutic use
• Humans
• Immunocompromised Host
• Invasive Fungal Infections / drug therapy
• Invasive Fungal Infections / etiology*
• Invasive Fungal Infections / microbiology
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
• Middle Aged
• Piperacillin, Tazobactam Drug Combination / therapeutic use
• Purines / administration & dosage
• Purines / adverse effects
• Quinazolinones / administration & dosage
• Quinazolinones / adverse effects
• Recurrence
• Rituximab / administration & dosage
• Rituximab / adverse effects
• Scedosporium / drug effects
• Scedosporium / isolation & purification*
• Triazoles / therapeutic use
• Valacyclovir / therapeutic use
• Vidarabine / administration & dosage
• Vidarabine / adverse effects
• Vidarabine / analogs & derivatives